Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Bioconjugate chemistry

• Publication date

  2004-10-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC049868VPMID 15546192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of potent monoclonal antibody auristatin conjugates for cancer therapy

  2003cited by this paper
• Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

  2003cited by this paper
• Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.

  2003cited by this paper
• Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.

  2003cited by this paper
• A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models.

  2002cited by this paper
• An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker.

  2002cited by this paper
• Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.

  2002cited by this paper
• PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.

  2001cited by this paper
• Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.

  2001cited by this paper
• Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.

  2001cited by this paper
• Efficient synthesis of the 3'-phenolic metabolite of paclitaxel.

  2001cited by this paper
• A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo

  2000cited by this paper
• Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapy.

  2000cited by this paper
• Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.

  1999cited by this paper
• Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.

  1999cited by this paper
• Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate.

  1999cited by this paper
• Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.

  1998cited by this paper
• Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.

  1997cited by this paper
• Activity of paclitaxel liposome formulations against human ovarian tumor xenografts

  1997cited by this paper
• Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

  1996cited by this paper
• In vivo modulators of antibody kinetics.

  1996cited by this paper
• Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.

  1996cited by this paper
• Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug

  1996cited by this paper
• Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces

  1995cited by this paper
• Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells.

  1992cited by this paper
• Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity.

  1989cited by this paper
• Labeling of monoclonal antibodies with radionuclides.

  1989cited by this paper
• Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

  1981cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper

• Novel Carboxylated Chitosan-Based Triptolide Conjugate for the Treatment of Rheumatoid Arthritis

  2020cites this paper
• In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration

  2020cites this paper
• Self-assembly of a robust, reduction-sensitive camptothecin nanotube.

  2020cites this paper
• Modifications of the Self-Immolative Spacer PABOH in Antibody Drug Conjugates

  2019cites this paper
• Development of an enzyme-linked immunosorbent assay for camptothecin

  2019cites this paper
• Cancer Nanomedicine: Lessons for Immuno-Oncology.

  2017cites this paper
• Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer

  2017cites this paper
• Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer

  2016cites this paper
• Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.

  2016cites this paper
• The self-assembly of a camptothecin-lysine nanotube.

  2016cites this paper
• Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability

  2015cites this paper
• The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.

  2015cites this paper
• Modifications of the Self-Immolative Spacer PABOH in Antibody Drug Conjugates

  2014cites this paper
• Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.

  2014cites this paper
• Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.

  2013cites this paper
• Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.

  2013cites this paper
• The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol.

  2012cites this paper
• An investigation of the use of dendrimer-based carrier to cross cellular barrier

  2011cites this paper
• Self-assembled nanospheres as a novel delivery system for taxol: a molecular hydrogel with nanosphere morphology.

  2011cites this paper
• Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.

  2011cites this paper
• Coordination conjugates of therapeutic proteins with drug carriers: a new approach for versatile advanced drug delivery.

  2011cites this paper
• Macromolecules as taxane delivery systems

  2011cites this paper
• Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.

  2010cites this paper
• Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages.

  2009cites this paper
• In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.

  2009cites this paper
• Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel groups.

  2008cites this paper
• Conjugated chitosan as a novel platform for oral delivery of paclitaxel.

  2008cites this paper
• Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro.

  2007cites this paper
• Design and synthesis of paclitaxel conjugated with an ErbB2-recognizing peptide, EC-1.

  2007cites this paper
• Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.

  2007cites this paper
• Elektrophysiologische Charakterisierung künstlicher Ionenkanäle in lebenden Zellen

  2006cites this paper
• Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein.

  2006cites this paper
• Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

  2006cites this paper
• Antibody–cytotoxic agent conjugates for cancer therapy

  2005influential citation
• Essential properties of drug-targeting delivery systems.

  2005cites this paper
• Literature Alerts

  2005cites this paper